Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIGAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
YIPF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNRD1ASP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CAB39L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM208A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3orf22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01082 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VN1R5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCAIM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCG4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC17A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on